The FDA will open the application portal on Jan. 1 for the Voluntary Qualified Importal Program for fiscal year 2026, according to the agency. The voluntary, fee-based program provides importers with expedited review and importation of human and animal foods into the U.S. To participate in VQIP, food importers must meet certain eligibility requirements, including ensuring that the facilities of their foreign suppliers are certified through the FDA’s Accredited Third-Party Certification Program, the agency said.

On Dec. 12, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 11, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The FDA is seeking comments on industry guidance related to cosmetic product facility registrations and product listings, it said in a Federal Register notice. This guidance, which the agency published under the Modernization of Cosmetics Regulation Act of 2022, includes three draft frequently asked questions and answers within Appendix B. The FDA is accepting comments on the FAQs by Jan. 13. It will begin work on this final section of the guidance afterward. The rest of Appendix B has been finalized, according to the FDA.

On Dec. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 9, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

On Dec. 6, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 4, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On Dec. 2, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of: